Alira Health’s CDD Supports Alcami Acquisition of Pacific Pharmaceutical Services

This investment will enable the bicoastal geographic expansion of Alcami’s Pharma Storage and Services capabilities, thus allowing it to serve all US biotech and pharma hubs.

“We are delighted that Alcami’s acquisition of Pacific Pharmaceutical Services will facilitate the growth of Alcami’s Pharma Storage and Services capabilities, enabling it to cater to all biotech and pharma hubs across the United States,” said Dr. Michal Raciborski, Managing Partner Financial Sponsors at Alira Health. “Clients of PPS will also enjoy prompt access to Alcami’s extensive service portfolio, encompassing analytical development, testing, and full drug product development.”

“The Pacific Pharmaceutical Services acquisition is part of our highly intentional strategy to supercharge the capabilities of our pharma storage and services business with locations that best serve biotech and pharma clients across the country,” commented Bill Humphries, CEO of Alcami. “Adding PPS to the Alcami family cements our status as the U.S. CDMO for West Coast projects as we continue to focus on the stability and security that matter most in storage of pre-clinical and clinical materials.”

“I’m proud of the business we built, and look forward to partnering with Alcami,” PPS founder Scott Chadwick said. “Combining forces enables us to offer clients even more solutions with the same agile, flexible approach that continues to make us successful.”

For more information on the acquisition, read the press release at Alcami. To learn more about Alira Health’s commercial due diligence and other consulting and clinical services enabled by technology and real-world evidence, visit AliraHealth.com.